These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11555712)

  • 1. Epidemiologic trends in HIV-associated lymphomas.
    Clarke CA; Glaser SL
    Curr Opin Oncol; 2001 Sep; 13(5):354-9. PubMed ID: 11555712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical epidemiology of Hodgkin lymphoma in HIV-infected patients in the highly active antiretroviral therapy (HAART) era.
    Vilchez RA; Finch CJ; Jorgensen JL; Butel JS
    Medicine (Baltimore); 2003 Mar; 82(2):77-81. PubMed ID: 12640183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Non Hodgkin's and Hodgkin's lymphomas and HIV: frequency, outcome and immune response under HAART; Clermont-Ferrand University Hospital, 1991-2003].
    Jacomet C; Lesens O; Villemagne B; Darcha C; Tournilhac O; Henquell C; Cormerais L; Gourdon F; Peigue-Lafeuille H; Travade P; Beytout J; Laurichesse H
    Med Mal Infect; 2006 Mar; 36(3):157-62. PubMed ID: 16503104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of non-Hodgkin lymphomas and other haemolymphopoietic neoplasms in people with AIDS.
    Dal Maso L; Franceschi S
    Lancet Oncol; 2003 Feb; 4(2):110-9. PubMed ID: 12573353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
    Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
    J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [HAART and changes of epidemiology, treatment and prognosis of HIV-positive patients with Kaposi's sarcoma and lymphoma].
    Gabarre J; Bossi P
    Bull Cancer; 2003 May; 90(5):419-25. PubMed ID: 12850765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epidemiology of HIV-associated malignancies].
    Launay O; Guillevin L
    Bull Cancer; 2003 May; 90(5):387-92. PubMed ID: 12850760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer risk in people infected with human immunodeficiency virus in the United States.
    Engels EA; Biggar RJ; Hall HI; Cross H; Crutchfield A; Finch JL; Grigg R; Hylton T; Pawlish KS; McNeel TS; Goedert JJ
    Int J Cancer; 2008 Jul; 123(1):187-94. PubMed ID: 18435450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired immunodeficiency syndrome-related lymphoma in the era of highly active antiretroviral therapy.
    Thirlwell C; Sarker D; Stebbing J; Bower M
    Clin Lymphoma; 2003 Sep; 4(2):86-92. PubMed ID: 14556679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer incidence in the multicenter AIDS Cohort Study before and during the HAART era: 1984 to 2007.
    Seaberg EC; Wiley D; Martínez-Maza O; Chmiel JS; Kingsley L; Tang Y; Margolick JB; Jacobson LP;
    Cancer; 2010 Dec; 116(23):5507-16. PubMed ID: 20672354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Systemic HIV-non-Hodgkin lymphoma in the era of HAART. Natural history].
    Juzbasic S; Spina M; Vaccher E; Tirelli U
    Recenti Prog Med; 2001 Nov; 92(11):676-89. PubMed ID: 11765662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus/acquired immunodeficiency syndrome and cancer: past, present, and future.
    Engels EA; Goedert JJ
    J Natl Cancer Inst; 2005 Mar; 97(6):407-9. PubMed ID: 15769998
    [No Abstract]   [Full Text] [Related]  

  • 13. AIDS malignancies in the era of highly active antiretroviral therapy.
    Gates AE; Kaplan LD
    Oncology (Williston Park); 2002 May; 16(5):657-65; discussion 665, 668-70. PubMed ID: 12108891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.
    International Collaboration on HIV and Cancer
    J Natl Cancer Inst; 2000 Nov; 92(22):1823-30. PubMed ID: 11078759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing incidence and survival in patients with aids-related non-Hodgkin's lymphomas in the era of highly active antiretroviral therapy (HAART).
    Chow KU; Mitrou PS; Geduldig K; Helm EB; Hoelzer D; Brodt HR
    Leuk Lymphoma; 2001 Mar; 41(1-2):105-16. PubMed ID: 11342362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta.
    Gingues S; Gill MJ
    HIV Med; 2006 Sep; 7(6):369-77. PubMed ID: 16903981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. StatBite: Lymphoma incidence in HIV patients vs. general population.
    J Natl Cancer Inst; 2010 Jul; 102(14):1003. PubMed ID: 20616355
    [No Abstract]   [Full Text] [Related]  

  • 18. HIV-associated Hodgkin lymphoma.
    Carbone A; Gloghini A; Serraino D; Spina M
    Curr Opin HIV AIDS; 2009 Jan; 4(1):3-10. PubMed ID: 19339934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-testing and newly-diagnosed malignant lymphomas. The SAKK 96/90 registration study.
    D'Addario G; Dieterle A; Torhorst J; Maibach R; Stahel R; Egli F; Lohri A; Cavalli F; Fey M; Ketterer N; Cerny T
    Leuk Lymphoma; 2003 Jan; 44(1):133-8. PubMed ID: 12691153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AIDS malignancies in the era of highly active antiretroviral therapy.
    Gates AE; Kaplan LD
    Oncology (Williston Park); 2002 Apr; 16(4):441-51, 456, 459. PubMed ID: 12017534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.